Errol B. Desouza - Insider Trading & Ownership

Entity
Individual
Location
215 College Road, Paramus, NJ
Summary
The estimated net worth of Errol B. Desouza is at least $2.63M dollars as of June 10, 2024. Errol B. Desouza is the Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $2.23M. Errol B. Desouza is the Director of Alector, Inc. and owns shares of Alector, Inc. (ALEC) stock worth about $286K. Errol B. Desouza is the Director of Cyclerion Therapeutics, Inc. and owns shares of Cyclerion Therapeutics, Inc. (CYCN) stock worth about $102K. Errol B. Desouza is the Director of CATALYST BIOSCIENCES, INC. and owns shares of GYRE THERAPEUTICS, INC. (GYRE) stock worth about $14K.
All Insider Reports
All Insider Reports

Ownership of Errol B. Desouza

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RPRX Royalty Pharma plc Director $2.23M Jun 7, 2024
ALEC Alector, Inc. Director $286K Mar 19, 2024
CYCN Cyclerion Therapeutics, Inc. Director $102K Nov 30, 2023
GYRE GYRE THERAPEUTICS, INC. Director $14K Oct 1, 2021

Insider Transactions Reported by Errol B. Desouza:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.